RT Book, Section A1 Macres, Steven A1 Richeimer, Steven A1 Duran, Paul A2 Warfield, Carol A. A2 Bajwa, Zahid H. SR Print(0) ID 3419510 T1 Chapter 62. Adjuvant Analgesics T2 Principles & Practice of Pain Medicine, 2e YR 2004 FD 2004 PB The McGraw-Hill Companies PP New York, NY SN 9780071443494 LK accessanesthesiology.mhmedical.com/content.aspx?aid=3419510 RD 2024/10/13 AB Traditionally, the opioid analgesics and the nonsteroidal anti-inflammatory drugs have been the mainstay for primary analgesia. Numerous other agents, however, are available in our vast pharmacopeia that are beneficial as primary or adjuvant analgesics, particularly for chronic nonmalignant pain that is neuropathic in origin. This vast array of drugs includes the antidepressants, the anticonvulsants, systemic local anesthetics, psychostimulants, neuroleptics, autonomic drugs, calcium channel blockers, skeletal muscle relaxants, N-methyl-d-aspartate (NMDA) receptor antagonists, corticosteroids, capsaicin, cannabinoids, and various other miscellaneous agents (e.g., tramadol, lithium, magnesium, neuronal nicotinic acetylcholine receptor ligands, butyl-p-amino benzoate, bupivacaine microspheres, and SNX-111).